Dentsply Sirona Expands Board with Two New Directors
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
DENTSPLY SIRONA ( (XRAY) ) has shared an update.
On February 23, 2026, Dentsply Sirona’s board voted to expand its size from 11 to 13 members and, effective February 27, 2026, appointed veteran healthcare investment banker James D. Forbes and longtime public company CFO Brian P. McKeon as new directors. Forbes will join the Compensation & Human Capital Committee, while McKeon will serve on the Audit and Finance Committee and the Science and Technology Committee, and both will receive the same compensation as other non-employee directors.
The company framed the appointments as a key step in reinforcing board-level financial, strategic, and governance expertise to support execution of its Return-to-Growth action plan and long-term value creation efforts. As part of an ongoing board refresh, 15-year director Willie A. Deese informed the company on February 23, 2026, that he will retire and not stand for re-election at this year’s annual shareholders’ meeting, a move the board said was not due to any disagreement with the company.
The most recent analyst rating on (XRAY) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
The score is held down primarily by weak financial performance (declining sales, sizable losses, leverage risk, and deteriorating free cash flow). Technicals provide some near-term support with improving momentum above shorter-term averages, while valuation is only partly supported by the high dividend given ongoing losses. Earnings call guidance and impairment-related setbacks remain a key overhang, partially offset by recent governance and distribution partnership positives.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with a history of more than a century serving the dental industry and patients worldwide. The Charlotte, N.C.-based company develops, manufactures, and markets comprehensive dental and oral health solutions and other consumable medical devices under a portfolio of global brands, and its shares trade on Nasdaq under the symbol XRAY.
Average Trading Volume: 4,014,045
Technical Sentiment Signal: Sell
Current Market Cap: $2.49B
For an in-depth examination of XRAY stock, go to TipRanks’ Overview page.
